Does a Nitrofurazone Coated Bladder Catheter Reduce the Number of Urinary Tract Infections in Trauma

Status

UNKNOWN

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00192985

Enrollment

216

Registered

2005-09-19

Start date

2003-05-31

Completion date

2006-09-30

Last updated

2005-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trauma, Urinary Tract Infections

Brief summary

Urinary tract infections occurs in trauma. We investigate whether a nitrofurazone coated can reduce the number of urinary tract infections.

Detailed description

Urinary tract infection occurs in one in five patients as a complication following severe trauma. A new and approved urinary bladder catheter (Releen NF) has been introduced by the Danish company Coloplast A/S. Releen NF is expected to reduce the number of urinary tract infections, but this effect has not been investigated in trauma patients.

Interventions

DEVICENitrofuranzone coated bladder catheter

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Masking

SINGLE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Clinical suspicion of multiple trauma * Age \>/= 18 years * Direct referral from scene of accident * Indication for urinary bladder catherization

Exclusion criteria

* Major burn injury * HIV positiv * Pregnancy

Design outcomes

Primary

Measure	Time frame
urinary tract infections	—

Secondary

Measure	Time frame
length of stay	—

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 6, 2026